213767-19-2

Basic information

• Product Name: 3-chloro-4-[(1-methylethyl)oxy]benzoyl chloride
• Synonyms: 3-chloro-4-[(1-methylethyl)oxy]benzoyl chloride
• CAS NO: 213767-19-2
• Molecular Weight: 233.094
• Mol File: 213767-19-2.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: 3-chloro-4-[(1-methylethyl)oxy]benzoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-4-[(1-methylethyl)oxy]benzoyl chloride(213767-19-2)
• EPA Substance Registry System: 3-chloro-4-[(1-methylethyl)oxy]benzoyl chloride(213767-19-2)

Safety Data

• Hazardous Substances Data: 213767-19-2(Hazardous Substances Data)

Upstream product

• 3964-57-6 methyl 4-hydroxy-3-chlorobenzoate 
• 213598-06-2 methyl 3-chloro-4-isopropoxybenzoate 
• 3964-58-7 3-chloro-4-hydroxybenzoic acid 
• 1312008-54-0 1-methylethyl 3-chloro-4-[(1-methylethyl)oxy]benzoate 
• 122488-52-2 ethyl 4-isopropoxybenzoate 
• 13205-46-4 4-isopropoxybenzoic acid 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 213598-07-3 3-chloro-4-isopropoxy-benzoic acid 

Downstream Products

• 1165923-97-6 1,1-dimethylethyl 6-((3-chloro-4-(1-methylethyloxy)phenyl)carbonyloxyamino(imino)methyl)-5-methyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate 
• 1165946-81-5 1,1-dimethylethyl 9-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-[3-(methyloxy)-3-oxopropyl]-2,3-dihydro-1,4-benzoxazepine-4(5H)-carboxylate 
• 1165946-56-4 1,1-dimethylethyl 9-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-[2-(ethyloxy)-2-oxoethyl]-2,3-dihydro-1,4-benzoxazepine-4(5H)-carboxylate 
• 1165946-69-9 1,1-dimethylethyl 9-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-5-[4-(ethyloxy)-4-oxobutyl]-2,3-dihydro-1,4-benzoxazepine-4(5H)-carboxylate 
• 1192829-30-3 3-[5-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1-isoquinolinyl]-1-propanol 
• 1192829-34-7 5-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)isoquinoline 
• 1240137-67-0 3-chloro-N-{(1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide 
• 1240137-84-1 C₃₆H₃₂BrClN₄O₅ 
• 943297-37-8 3-chloro-N-{(1S)-2-[(N-methylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide 
• 1240137-95-4 3-chloro-N-{(1S)-2-(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)-1-[(3-methyl-2,5-dioxo-1-imidazolidinyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide 
• 1240137-96-5 3-chloro-N-((1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-{[4-(hydroxyacetyl)phenyl]methyl}ethyl)-4-[(1-methylethyl)oxy]benzamide 
• 1240138-02-6 3-chloro-N-{(1S)-1-(4-{[2-{4-[(2S)-2-[({3-chloro-4-[(1-methylethyl)oxy]phenyl}carbonyl)amino]-3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propyl]phenyl}-8-(1-hydroxyethyl)imidazo[1,2-a]pyridin-3-yl]acetyl}phenyl)-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide 
• 1240137-97-6 3-chloro-N-((1S)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-{[4-(oxoacetyl)phenyl]methyl}ethyl)-4-[(1-methylethyl)oxy]benzamide 
• 1240138-00-4 N, N'-([(2E)-1,4-dioxo-2-butene-1,4-diyl]bis{benzene-4,1-diyl[(2S)-3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1,2-propanediyl]})bis{3-chloro-4-[(1-methylethyl)oxy]benzamide} 

Relevant articles and documents

Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses

FTY720 is the first oral small molecule approved for the treatment of people suffering from relapsing-remitting multiple sclerosis. It is a potent agonist of the S1P1 receptor, but its lack of selectivity against the S1P3 receptor ha

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptor are disclosed.